Document is current
Any future updates will be listed below
-
Authors
Pan, Tianhong https://orcid.org/0000-0001-6891-2063
Lin, Song-Chang
Lee, Yu-Chen
Yu, Guoyu
Song, Jian H.
Pan, Jing
Titus, Mark
Satcher, Robert L.
Panaretakis, Theocharis
Logothetis, Christopher
Yu-Lee, Li-Yuan
Lin, Sue-Hwa https://orcid.org/0000-0002-6122-4054
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA174798, 5P50 CA140388, P30 CA16672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 19 February 2021
Revised: 14 May 2021
Accepted: 27 May 2021
First Online: 14 June 2021
Competing interests
: C.L. reports receiving commercial research grants from Bayer, Sanofi, Janssen, Astellas Pharma, Pfizer; and honoraria from Bayer, Janssen, Sanofi, Astellas Pharma. The other authors declare no competing interests.
